Patents by Inventor Ka Wang

Ka Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090317805
    Abstract: The present invention identifies biomarkers that are diagnostic of nerve cell injury, organ injury, and/or neuronal disorders. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of nerve injury, the cell(s) involved in the injury, and the subcellular localization of the injury.
    Type: Application
    Filed: June 11, 2008
    Publication date: December 24, 2009
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Ka-Wang (Kevin) Wang, Ming Chen Liu
  • Patent number: 7611858
    Abstract: Traumatic insult to the brain leads to a degradation of low molecular weight of cannabinoid type 1 receptor (CB1) and generation of high molecular weight complexes in the cortex and hippocampus, as assessed by both N-terminal and C-terminal specific antibodies. The formation and release of CB1 oligomers was dramatically increased into CSF within 1 hour following traumatic brain insult. Novel CB1 receptor-based, prognostic markers of traumatic brain injury and other forms of brain injury are disclosed. A method of repopulating damaged neural cells by proliferation of a subgroup of neural progenitor cells is described. Targeting CB1 receptors for therapeutic neuroprotection in TBI is also disclosed.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: November 3, 2009
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Stanislav Svetlov, Ronald L. Hayes, Ka-Wang (Kevin) Wang
  • Patent number: 7523403
    Abstract: A placeholder control object is positioned on a page of a web site hosted by a content management server (CMS). The CMS stores the page with the placeholder control object therein and serves same to a requestor thereof. In a presentation mode, the page and the placeholder control object therein are served by the CMS to a requesting viewer of the page at a browser thereof. In such presentation mode, the placeholder control object displays associated content to the viewer within the browser thereof. In an authoring mode, the page and the placeholder control object therein are served by the CMS to a requesting designer of the page at a browser thereof. In such authoring mode, the placeholder control object allows editing of the associated content by the designer within the browser thereof and saving the edited content to the CMS.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: April 21, 2009
    Assignee: Microsoft Corporation
    Inventors: Burhan Kerem Karatal, Anthony Lawrence Jackson, Kevin Ka-Wang Lui, Arul Kumaravel
  • Publication number: 20090087868
    Abstract: The present invention identifies biomarkers that are diagnostic of nerve cell injury and/or neuronal disorders. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of nerve injury, the cell(s) involved in the injury, and the subcellular localization of the injury.
    Type: Application
    Filed: June 11, 2008
    Publication date: April 2, 2009
    Inventors: Kevin Ka-Wang Wang, Ronald Hayes, Ming Chen Liu, Monika Oli
  • Publication number: 20090068691
    Abstract: A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP-II) and comparing to a control. An increase of EMAP-II indicates the presence of traumatic brain injury and a decrease of EMAP-II indicates the presence of ischemic brain injury.
    Type: Application
    Filed: October 28, 2008
    Publication date: March 12, 2009
    Inventors: Jitendra Ramanlal Dave, Changping Yao, Anthony Joseph Williams, Xi-Chun May, Frank Casper Tortella, Ka-Wang Kevin Wang, Ronald Lawrence Hayes
  • Publication number: 20080311036
    Abstract: In vivo determination of regional damage with neural and organ injury specific imaging agents. Rapid, and non-invasive imaging compositions and methods for assessment of the extent of neurotoxic cell loss or nervous system damage resulting from nervous system injury due to ischemia, stroke, trauma, chemical or electrical insult, acute drug overdose or exposure to substance abuse (such as “recreational drugs”) infection or other insults. The same or similar rapid, and non-invasive imaging compositions and methods for assessment of the extent of the organ injury comprises any damage, injury or infection, functional failure to specific organs such as liver, kidney, prostate, lung, skeletal muscle, heart, pancreas, stomach, small and large intestine, bladder and the reproductive system as well as damage, injury or infection, functional failure to multi-organs, trauma-hemorrhagic shock and sepsis.
    Type: Application
    Filed: May 11, 2006
    Publication date: December 18, 2008
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Kevin Ka-Wang Wang, Ronald L. Hayes, Lewis R. Baxter, JR., Laszlo Prokai
  • Patent number: 7456027
    Abstract: The present invention identifies biomarkers that are diagnostic of nerve cell injury, organ injury, and/or neuronal disorders. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of nerve injury, the cell(s) involved in the injury, and the subcellular localization of the injury.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: November 25, 2008
    Assignees: University of Florida Research Foundation, Inc., Banyan Biomarkers, Inc.
    Inventors: Kevin Ka-Wang Wang, Ronald Hayes, Ming Chen Liu, Monika Oli
  • Publication number: 20080244383
    Abstract: A data system has a data structure with a posting corresponding to a set of pieces of content to be served. The posting includes a description of each piece of content including a name, a type, and a location thereof. The posting is presented to a user according to a pointed-to template. The template includes a placeholder within which each piece of content is to be presented, and positioning information setting forth a layout position for each placeholder. The template points to a separate content definition information module that includes content definition information for each placeholder including the name and type of the corresponding piece of content. Such name and type matches a corresponding name and type as set forth in the posting.
    Type: Application
    Filed: June 16, 2008
    Publication date: October 2, 2008
    Applicant: Microsoft Corporation
    Inventors: Nicholas Duncan, Kevin Ka-Wang Lui, Patrick Carl Miller, Mark Poernbacher
  • Patent number: 7396654
    Abstract: The present invention identifies biomarkers that are diagnostic of nerve cell injury and/or neuronal disorders. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of nerve injury, the cell(s) involved in the injury, and the subcellular localization of the injury.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: July 8, 2008
    Assignees: University of Florida Research Foundation, Inc., Banyan Biomarkers, Inc.
    Inventors: Ronald Hayes, Kevin Ka-Wang Wang, Ming Chen Liu, Monika Oli
  • Patent number: 7389472
    Abstract: A data system has a data structure with a posting corresponding to a set of pieces of content to be served. The posting includes a description of each piece of content including a name, a type, and a location thereof. The posting is presented to a user according to a pointed-to template. The template includes a placeholder within which each piece of content is to be presented, and positioning information setting forth a layout position for each placeholder. The template points to a separate content definition information module that includes content definition information for each placeholder including the name and type of the corresponding piece of content. Such name and type matches a corresponding name and type as set forth in the posting.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: June 17, 2008
    Assignee: Microsoft Corporation
    Inventors: Nicholas Duncan, Kevin Ka-Wang Lui, Patrick Carl Miller, Mark Poernbacher
  • Patent number: 7259166
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Grant
    Filed: April 10, 2006
    Date of Patent: August 21, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Wendy Lea Corbett, Joseph Samuel Grimsby, Nancy-Ellen Haynes, Robert Francis Kester, Paige Erin Mahaney, Jagdish Kumar Racha, Ramakanth Sarabu, Ka Wang
  • Patent number: 7105671
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: September 12, 2006
    Assignee: Hoffmann-la Roche Inc.
    Inventors: Wendy Lea Corbett, Joseph Samuel Grimsby, Nancy-Ellen Haynes, Robert Francis Kester, Paige Erin Mahaney, Jagdish Kumar Racha, Ramakanth Sarabu, Ka Wang
  • Publication number: 20060178429
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 10, 2006
    Publication date: August 10, 2006
    Inventors: Wendy Corbett, Joseph Grimsby, Nancy-Ellen Haynes, Robert Kester, Paige Mahaney, Jagdish Racha, Ramakanth Sarabu, Ka Wang
  • Patent number: 7052854
    Abstract: Systems and methods for the ex vivo diagnostic analysis of samples of bodily fluids, including exhaled breath and blood. The present invention uses nanostructure-based assemblies in combination with sensor technology to provide an efficient and accurate means for identifying the presence of a target analyte/biomarker in a sample of bodily fluid. In a preferred embodiment, the nanostructure-based assemblies of the present invention include detecting means such as RNA oligonucleotide chains or “apparatus” and releasable surrogate markers such as DMSO.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: May 30, 2006
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Richard J. Melker, Ronald L. Hayes, Ka-Wang Kevin Wang, Donn Michael Dennis
  • Publication number: 20060040318
    Abstract: Systems and methods for the ex vivo diagnostic analysis of samples of bodily fluids, including exhaled breath and blood. The present invention uses nanostructure-based assemblies in combination with sensor technology to provide an efficient and accurate means for identifying the presence of a target analyte/biomarker in a sample of bodily fluid. In a preferred embodiment, the nanostructure-based assemblies of the present invention include detecting means such as RNA oligonucleotide chains or “aptamers” and releasable surrogate markers such as DMSO.
    Type: Application
    Filed: October 2, 2003
    Publication date: February 23, 2006
    Inventors: Richard Melker, Ronald Hayes, Ka-Wang Wang, Donn Dennis
  • Publication number: 20040225652
    Abstract: A data system has a data structure with a posting corresponding to a set of pieces of content to be served. The posting includes a description of each piece of content including a name, a type, and a location thereof. The posting is presented to a user according to a pointed-to template. The template includes a placeholder within which each piece of content is to be presented, and positioning information setting forth a layout position for each placeholder. The template points to a separate content definition information module that includes content definition information for each placeholder including the name and type of the corresponding piece of content. Such name and type matches a corresponding name and type as set forth in the posting.
    Type: Application
    Filed: May 7, 2003
    Publication date: November 11, 2004
    Applicant: Microsoft Corporation
    Inventors: Nicholas Duncan, Kevin Ka-Wang Lui, Patrick Carl Miller, Mark Poernbacher
  • Publication number: 20030225283
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 23, 2003
    Publication date: December 4, 2003
    Inventors: Wendy Lea Corbett, Joseph Samuel Grimsby, Nancy-Ellen Haynes, Robert Francis Kester, Paige Erin Mahaney, Jagdish Kumar Racha, Ramakanth Sarabu, Ka Wang
  • Publication number: 20020001806
    Abstract: Polynucleotides (sense and antisense) and polypeptides of a novel caspase-3 splicing variant, termed caspase-3s, are described as research reagents, antiapoptotic agents, neuroprotective agents, pharmaceutical compositions, antitumor agents and agents that protect neuronal cells from apoptotic cell death.
    Type: Application
    Filed: March 16, 2001
    Publication date: January 3, 2002
    Inventors: Yuanhui Huang, Yi Sun, Kevin Ka-Wang Wang
  • Patent number: 5760048
    Abstract: The invention covers a novel series of .alpha.-mercaptoacrylic acid derivatives that inhibit both calpain I and calpain II with a high affinity and selectivity. The compounds are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders, brain injury, spinal cord, and peripheral nerve injury, cardiac infarction, cataracts, inflammation, restenosis, muscular dystrophy, and platelet aggregation. Pharmaceutical compositions, methods of using processes for preparing and novel intermediates useful in the processes are also disclosed.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: June 2, 1998
    Assignee: Warner-Lambert Company
    Inventors: Kevin Ka-Wang Wang, Po-Wai Yuen
  • Patent number: 5679680
    Abstract: The invention covers a novel series of .alpha.-substituted hydrazides that inhibit both calpain I and calpain II. They are non-peptide irreversible active site inhibitors of calpain. The compounds are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders, brain injury, spinal cord, and peripheral nerve injury, cardiac infarction, cataracts, inflammation, restenosis, muscular dystrophy, and platelet aggregation. Pharmaceutical compositions, methods of using processes for preparing and novel intermediates useful in the processes are also disclosed.
    Type: Grant
    Filed: February 16, 1995
    Date of Patent: October 21, 1997
    Assignee: Warner-Lambert Company
    Inventors: Kevin Ka-Wang Wang, Po-Wai Yuen